These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4784814)

  • 1. Serum hydantoin levels with various proprietary preparations.
    Ahuja GK; Ali SR; Rao BS; Mani KS
    Neurol India; 1973 Sep; 21(3):119-23. PubMed ID: 4784814
    [No Abstract]   [Full Text] [Related]  

  • 2. [The consequence of the preparation factors for the effect of the drug].
    Johnsgård M; Pedersen AO
    Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma phenytoin levels produced by various phenytoin preparations.
    Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J
    Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methods for biopharmaceutical evaluation of enteric gelatin capsules: use of Enterocaps gelatin capsules].
    Aiache JM; Aiache S; Jeanneret A; Cornat F
    Boll Chim Farm; 1975 Nov; 114(11):636-50. PubMed ID: 1220721
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phenytoin pharmacokinetics as a function of the preparation: capsules, commercial tablets and experimental tablets].
    Almaşu I; Leucuţa SE
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):283-93. PubMed ID: 2951833
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenytoin toxicity when tablets substituted for capsules.
    Kirshner HS
    N Engl J Med; 1983 May; 308(18):1106. PubMed ID: 6835331
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability of the acetylsalicylic acid tablets registered in Finland.
    Perälä-Suominen A
    Ann Clin Res; 1974; 6(0):suppl 11:26-33. PubMed ID: 4855462
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of phenytoin from various pharmaceutical preparations in children.
    Manson JI; Beal SM; Magarey A; Pollard AC; O'Reilly WJ; Sansom LN
    Med J Aust; 1975 Oct; 2(15):590-2. PubMed ID: 1196223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single daily dose of diphenylhydantoin in children.
    Buchanan RA; Turner JL; Moyer CE; Heffelfinger JC
    J Pediatr; 1973 Sep; 83(3):479-83. PubMed ID: 4725154
    [No Abstract]   [Full Text] [Related]  

  • 13. Enteric-coated insulin capsules: a combination with or a replacement of oral hypoglycaemic drugs.
    Hosny EA; el-Bagory IM; al-Jenoobi FI
    Boll Chim Farm; 2002; 141(5):379-84. PubMed ID: 12481381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medicinal capsules].
    Khanina GI; Batkina ZV; Pospelova VV; Dedukh NG
    Farmatsiia; 1974; (6):67-70. PubMed ID: 4618815
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic inequivalence--clinical observations.
    Prescott LF; Nimmo J
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():288-303. PubMed ID: 5317801
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of single and multiple doses of phenytoin in man.
    Lund L; Alvan G; Berlin A; Alexanderson B
    Eur J Clin Pharmacol; 1974; 7(2):81-6. PubMed ID: 4853604
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonequivalence of phenytoin capsules and tablets.
    Raebel MA
    N Engl J Med; 1983 Oct; 309(15):925. PubMed ID: 6888489
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced seizure control due to spoiled phenytoin capsules.
    Cloyd JC; Gumnit RJ; Lesar TS
    Ann Neurol; 1980 Feb; 7(2):191-3. PubMed ID: 7369725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin therapy: a comparison of one 300 mg capsule with three 100 mg capsules.
    Baars R; Rapp R; Young B; Canafax D
    Ann Neurol; 1978 Jul; 4(1):90. PubMed ID: 697331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.